Clinical Trial Update: Active Immunization of Sibling Bone Marrow Transplant Donors Against Purified Myeloma Protein of the Recipient Undergoing Allogeneic Bone Marrow Transplantation [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating immunization of sibling bone marrow donors against the recipient's purified myeloma protein undergoing allogeneic bone marrow transplan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease
• Multiple Myeloma

Drugs mentioned

• Purified myeloma protein immunogen (Purified myeloma protein immunogen)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Graft vs Host Disease, Multiple Myeloma | Phase 3 | Status: COMPLETED